IO Biotech Inc (IOBT) Financials

$0.01

$0.00 (3.66%)

As on 08-Jun-2026 09:30EDT

Market cap

$3 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.85	--	--	--	--	--
Cost of Revenue	0.91	0.85	0.76	0.54	--	--
Gross Profit	-0.91	-0.85	-0.76	-0.54	--	--
Operating Expenses	91.14	94.33	90.69	70.88	41.23	10.15
Operating Profit (EBIT)	-92.05	-95.18	-91.44	-71.42	-41.23	-10.15
Other Income	--	--	--	1.54	--	--
Profit before Tax	-89.30	-94.05	-85.23	-70.19	-67.81	-12.04
Provision for Tax	-0.96	1.44	0.85	1.27	0.07	0.03
Profit after Tax (Net Income)	-88.35	-95.49	-86.08	-71.46	-67.88	-12.04
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-71.46	-74.99	-14.59

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	0.91	47.02	133.16	138.85	211.92	2.60
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	20.73	1.20	1.84	2.28	0.06	37.91
Current Liabilities	18.31	19.49	15.72	10.68	10.31	3.05
Total Liabilities	58.27	67.70	150.72	151.81	222.29	5.65

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	3.13	2.75	3.46	3.59	0.55	0.02
Current Assets	36.83	64.95	147.26	148.22	221.74	5.64
Total Assets	58.27	67.70	150.72	151.81	222.29	5.65
Total Debt*	1.46	1.92	2.49	2.79	--	--
Net Current Assets	18.52	45.47	131.54	137.54	211.43	2.59

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-82.35	-71.74	-59.73	-40.65	-9.96
Cash Flow from Investing Activities	--	-0.04	-0.32	-0.69	-0.15	-0.15
Cash from Financing Activities	--	--	71.86	187.54	252.95	5.10
Net Cash Inflow / Outflow	--	--	--	-60.42	--	--

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-1.34	-1.45	-1.31	-2.48	-2.64	-1.04
Cash EPS ($)	--	-1.44	-1.30	-2.46	-2.64	-1.04
Adjusted Book Value ($)	--	0.71	2.02	4.82	8.24	0.23
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.25	-1.09	-2.07	-1.58	-0.86
Free Cash Flow per Share ($)	--	-1.25	-1.09	-2.10	-1.59	-0.86

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-103.47	-62.09	-40.42	-63.28	-245.88
ROE (%)	-646.46	-106.00	-63.29	-40.74	-63.28	-2,127.56
ROA (%)	-107.57	-87.44	-56.91	-38.20	-59.56	-159.75
EBIT Margin (%)	-10,372.35	--	--	--	--	--
Net Margin (%)	-10,394.00	--	--	-4,637.12	--	--
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-23.42	--	--	--	--	--
EBIT Growth (%)	0.93	-10.34	-21.96	-3.61	-202.81	-107.46
Net Profit Growth (%)	2.20	-10.93	-20.47	-5.27	-463.69	-12.03
EPS Growth (%)	2.35	-0.11	0.47	0.06	-1.53	--
Book Value Growth (%)	-98.76	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.63	-1.44	-0.93	-2.43	--
Price / Book Value	0.65	1.29	0.93	0.48	0.78	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	1.36	-0.03	0.20	1.06	0.70	--
Close Price ($)	0.36	0.92	1.88	2.30	6.40	--
High Price ($)	2.79	2.10	3.30	9.77	17.88	--
Low Price ($)	0.32	0.66	0.82	2.15	6.02	--
Market Cap ($ Cr)	3.45	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	18.29	0.04	0.02	0.02	--	--
Short term debt to equity ratio	0.86	0.02	0.00	0.00	--	--
Current Ratio	2.01	3.33	9.37	13.88	21.52	1.85
Quick Ratio	2.01	--	--	14.03	21.72	1.73
Interest Coverage	-77.41	--	-28,410.33	-231.40	-186.84	-856.73

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	116.59	--	--	--	--	--
Asset Turnover	0.01	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	-740.65	-1,225.62	--	--
Payable days	--	1,836.79	1,904.03	2,682.56	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.